{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:54:29Z","timestamp":1791136469583,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4207,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ymthe.2004.12.017","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T07:34:00Z","timestamp":1107243240000},"page":"578-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Eradication of epstein\u2013barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1"],"prefix":"10.1016","volume":"11","author":[{"given":"Md.","family":"Nasimuzzaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitaka","family":"Dohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenobu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashel","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakako","family":"Kumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wakiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shosuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.12.017_bib1","first-page":"2575","article-title":"Epstein\u2013Barr virus","volume":"Vol. 2","author":"Rickinson","year":"2001"},{"key":"10.1016\/j.ymthe.2004.12.017_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein\u2013Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2004.12.017_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein\u2013Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2004.12.017_bib4","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","article-title":"Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein\u2013Barr virus latent infection protein","volume":"91","author":"Imai","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.12.017_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/bjc.1996.412","article-title":"Transcriptional analysis of Epstein\u2013Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells","volume":"74","author":"Sugiura","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2004.12.017_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the Workshop on Nasal and Related Extranodal Angiocentric T\/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib7","first-page":"2511","article-title":"Epstein\u2013Barr virus and its replication","volume":"Vol. 2","author":"Kieff","year":"2001"},{"key":"10.1016\/j.ymthe.2004.12.017_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/309078a0","article-title":"Immortalization of monkey epithelial cells by specific fragments of Epstein\u2013Barr virus DNA","volume":"309","author":"Griffin","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2004.12.017_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/340393a0","article-title":"Genetic analysis of immortalizing functions of Epstein\u2013Barr virus in human B lymphocytes","volume":"340","author":"Hammerschmidt","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2004.12.017_bib10","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/j.1460-2075.1989.tb08438.x","article-title":"A transforming function of the BARF1 gene encoded by Epstein\u2013Barr virus","volume":"8","author":"Wei","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib11","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/jvi.68.9.6069-6073.1994","article-title":"Isolation of Epstein\u2013Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV","volume":"68","author":"Shimizu","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib12","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","article-title":"Expression of Epstein\u2013Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice","volume":"15","author":"Wilson","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib13","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1073\/pnas.95.20.11963","article-title":"Expression of the Epstein\u2013Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice","volume":"95","author":"Kulwichit","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.12.017_bib14","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","article-title":"Oncogenic role of Epstein\u2013Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line Akata","volume":"73","author":"Komano","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1128\/JVI.73.2.1286-1292.1999","article-title":"Epstein\u2013Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression","volume":"73","author":"Nishikawa","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib16","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1093\/emboj\/19.24.6742","article-title":"Epstein\u2013Barr virus-encoded poly(A)\u2212 RNA supports Burkitt\u2019s lymphoma growth through interleukin-10 induction","volume":"19","author":"Kitagawa","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib17","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1128\/JVI.75.20.9977-9982.2001","article-title":"Replacement of the Epstein\u2013Barr virus plasmid with the EBER plasmid in Burkitt\u2019s lymphoma cells","volume":"75","author":"Maruo","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib18","first-page":"161","article-title":"Epstein\u2013Barr virus infection of human epithelial cells","volume":"258","author":"Imai","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/j.1460-2075.1990.tb07398.x","article-title":"Alternative splicing dictates translational start in Epstein\u2013Barr virus transcripts","volume":"9","author":"Rogers","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib20","doi-asserted-by":"crossref","first-page":"10565","DOI":"10.1073\/pnas.92.23.10565","article-title":"Redefining the Epstein\u2013Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines","volume":"92","author":"Schaefer","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.12.017_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","article-title":"Stable replication of plasmids derived from Epstein\u2013Barr virus in various mammalian cells","volume":"313","author":"Yates","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2004.12.017_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","article-title":"EBNA-1: a protein pivotal to latent infection by Epstein\u2013Barr virus","volume":"10","author":"Leight","year":"2000","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib23","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/jvi.69.4.2633-2636.1995","article-title":"An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein\u2013Barr virus LMP gene","volume":"69","author":"Gahn","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib24","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1128\/jvi.70.9.5758-5768.1996","article-title":"OriP is essential for EBNA gene promoter activity in Epstein\u2013Barr virus-immortalized lymphoblastoid cell lines","volume":"70","author":"Puglielli","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib25","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/jvi.66.8.4654-4661.1992","article-title":"The Epstein\u2013Barr virus nuclear protein 1 promoter active in type I latency is autoregulated","volume":"66","author":"Sample","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib26","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1002\/j.1460-2075.1994.tb06810.x","article-title":"EBNA-1, the major nuclear antigen of Epstein\u2013Barr virus, resembles \u2018RGG\u2019 RNA binding proteins","volume":"13","author":"Snudden","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib27","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1128\/jvi.69.12.8155-8158.1995","article-title":"Epstein\u2013Barr virus induction of recombinase-activating genes RAG1 and RAG2","volume":"69","author":"Srinivas","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/JVI.73.2.1630-1636.1999","article-title":"Expression of Epstein\u2013Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428","volume":"73","author":"Kube","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib29","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1093\/emboj\/18.20.5755","article-title":"Enhancement of hepatitis C virus replication by Epstein\u2013Barr virus-encoded nuclear antigen 1","volume":"18","author":"Sugawara","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib30","doi-asserted-by":"crossref","first-page":"29987","DOI":"10.1074\/jbc.M303977200","article-title":"Protein profiling with Epstein\u2013Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP\/USP7","volume":"278","author":"Holowaty","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.12.017_bib31","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1128\/JVI.74.15.6748-6759.2000","article-title":"Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein\u2013Barr virus nuclear antigen 1","volume":"74","author":"Steigerwald-Mullen","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib32","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1128\/JVI.74.11.4939-4948.2000","article-title":"Functional analyses of the EBNA1 origin DNA binding protein of Epstein\u2013Barr virus","volume":"74","author":"Ceccarelli","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib33","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/jvi.76.5.2480-2490.2002","article-title":"Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein\u2013Barr nuclear antigen 1","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib34","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/jvi.71.3.1766-1775.1997","article-title":"Dominant-negative inhibitors of EBNA-1 of Epstein\u2013Barr virus","volume":"71","author":"Kirchmaier","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib35","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1089\/hum.1998.9.17-2577","article-title":"Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method","volume":"9","author":"Mizuguchi","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.12.017_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-1119(02)00410-9","article-title":"Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes","volume":"285","author":"Mizuguchi","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2004.12.017_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00571929","article-title":"An Epstein\u2013Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA","volume":"5","author":"Takada","year":"1991","journal-title":"Virus Genes"},{"key":"10.1016\/j.ymthe.2004.12.017_bib38","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/jvi.70.10.7260-7263.1996","article-title":"Clonal propagation of Epstein\u2013Barr virus (EBV) recombinants in EBV-negative Akata cells","volume":"70","author":"Shimizu","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib39","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","article-title":"Cell-to-cell contact as an efficient mode of Epstein\u2013Barr virus infection of diverse human epithelial cells","volume":"72","author":"Imai","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib40","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1002\/j.1460-2075.1995.tb00040.x","article-title":"Persistent Epstein\u2013Barr virus infection in a human T-cell line: unique program of latent virus expression","volume":"14","author":"Yoshiyama","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2004.12.017_bib41","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1128\/JVI.78.8.3984-3993.2004","article-title":"Epstein\u2013Barr virus nuclear antigen leader protein induces expression of thymus and activation-regulated chemokine in B cells","volume":"78","author":"Kanamori","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","article-title":"Different Epstein\u2013Barr virus\u2013B cell interactions in phenotypically distinct clones of a Burkitt\u2019s lymphoma cell line","volume":"71","author":"Gregory","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib43","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/515290","article-title":"Eradication of latent Epstein\u2013Barr virus by hydroxyurea alters the growth-transformed cell phenotype","volume":"177","author":"Chodosh","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2004.12.017_bib44","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.211556598","article-title":"Epstein\u2013Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth","volume":"98","author":"Kang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.12.017_bib45","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein\u2013Barr virus provides a survival factor to Burkitt\u2019s lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.12.017_bib46","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446","article-title":"Epstein\u2013Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection","volume":"87","author":"Imai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.12.017_bib47","first-page":"51","article-title":"The epidemiology of Epstein\u2013Barr virus-associated human cancer","volume":"45","author":"Levin","year":"1998","journal-title":"Gann Monogr. Cancer Res."},{"key":"10.1016\/j.ymthe.2004.12.017_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein\u2013Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2004.12.017_bib49","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1182\/blood-2002-05-1514","article-title":"Generating CTLs against the subdominant Epstein\u2013Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies","volume":"101","author":"Gottschalk","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.12.017_bib50","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V97.4.835","article-title":"An Epstein\u2013Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs","volume":"97","author":"Gottschalk","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.12.017_bib51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/nm1295-1303","article-title":"Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein\u2013Barr virus","volume":"1","author":"Banerjee","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2004.12.017_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/hum.1996.7.5-647","article-title":"Use of Epstein\u2013Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia","volume":"7","author":"Judde","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.12.017_bib53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/nm1296-1379","article-title":"Epstein\u2013Barr virus-driven gene therapy for EBV-related lymphomas","volume":"2","author":"Franken","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2004.12.017_bib54","first-page":"1485","article-title":"Induction of lytic Epstein\u2013Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo","volume":"59","author":"Westphal","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.12.017_bib55","first-page":"171","article-title":"Tumor-targeted gene therapy for nasopharyngeal carcinoma","volume":"62","author":"Li","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.12.017_bib56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood.V86.2.659.bloodjournal862659","article-title":"Heterogeneous expression of Epstein\u2013Barr virus latent proteins in endemic Burkitt\u2019s lymphoma","volume":"86","author":"Niedobitek","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.12.017_bib57","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V91.4.1373","article-title":"Epstein\u2013Barr virus (EBV) in endemic Burkitt\u2019s lymphoma: molecular analysis of primary tumor tissue","volume":"91","author":"Tao","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.12.017_bib58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.10372","article-title":"Promiscuous expression of Epstein\u2013Barr virus genes in Burkitt\u2019s lymphoma from the central African country Malawi","volume":"99","author":"Xue","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2004.12.017_bib59","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood.V84.2.582.582","article-title":"Epstein\u2013Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein\u2013Barr virus-immortalized B cells","volume":"84","author":"Roth","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.12.017_bib60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(00)80397-0","article-title":"Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing","volume":"7","author":"Blake","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2004.12.017_bib61","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4049\/jimmunol.169.3.1593","article-title":"Epstein\u2013Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt\u2019s lymphoma cells","volume":"169","author":"Paludan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib62","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein\u2013Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.12.017_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/310207a0","article-title":"DNA sequence and expression of the B95-8 Epstein\u2013Barr virus genome","volume":"310","author":"Baer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2004.12.017_bib64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7883\/yoken1952.47.157","article-title":"A simple and efficient method for purification of infectious recombinant adenovirus","volume":"47","author":"Kanegae","year":"1994","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.ymthe.2004.12.017_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0042-6822(76)90144-6","article-title":"Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines","volume":"74","author":"Prichett","year":"1976","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.12.017_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000133580","article-title":"Chromosomal localization of the OX44 (CD53) leukocyte antigen gene in man and rodents","volume":"64","author":"Taguchi","year":"1993","journal-title":"Cytogenet. Cell Genet."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604015941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604015941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:48:44Z","timestamp":1761500924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604015941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1525001604015941"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.12.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of epstein\u2013barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American Society of Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}